| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adverse events after first COVID-19 vaccination in patients with autoimmune diseases
|
Boekel, Laura
|
|
|
3 |
8 |
p. e542-e545
|
artikel
|
| 2 |
Calcinosis cutis universalis secondary to scleroderma-polymyositis overlap syndrome
|
Colquhoun, Matthew
|
|
|
3 |
8 |
p. e604
|
artikel
|
| 3 |
Central sensitisation: causes, therapies, and terminology
|
Cayrol, Timothée
|
|
|
3 |
8 |
p. e548
|
artikel
|
| 4 |
Central sensitisation: causes, therapies, and terminology
|
Minhas, Sonica
|
|
|
3 |
8 |
p. e546
|
artikel
|
| 5 |
Central sensitisation: causes, therapies, and terminology
|
Mehta, Puja
|
|
|
3 |
8 |
p. e546-e547
|
artikel
|
| 6 |
Central sensitisation: causes, therapies, and terminology
|
Weisman, Asaf
|
|
|
3 |
8 |
p. e547-e548
|
artikel
|
| 7 |
Central sensitisation: causes, therapies, and terminology – Authors' reply
|
Nijs, Jo
|
|
|
3 |
8 |
p. e548-e549
|
artikel
|
| 8 |
Clinician-reported outcome measures in lupus trials: a problem worth solving
|
Connelly, Kathryn
|
|
|
3 |
8 |
p. e595-e603
|
artikel
|
| 9 |
Composite of Relevant Endpoints for Sjögren's Syndrome (CRESS): development and validation of a novel outcome measure
|
Arends, Suzanne
|
|
|
3 |
8 |
p. e553-e562
|
artikel
|
| 10 |
CRESS: improving the assessment of disease activity in Sjögren's syndrome
|
Isenberg, David A
|
|
|
3 |
8 |
p. e534-e535
|
artikel
|
| 11 |
Deciphering the cytokine fingerprint of macrophage activation syndrome
|
Henderson, Lauren A
|
|
|
3 |
8 |
p. e535-e538
|
artikel
|
| 12 |
Definition and validation of serum biomarkers for optimal differentiation of hyperferritinaemic cytokine storm conditions in children: a retrospective cohort study
|
Kessel, Christoph
|
|
|
3 |
8 |
p. e563-e573
|
artikel
|
| 13 |
EULAR 2021
|
Brooks, Helen
|
|
|
3 |
8 |
p. e551-e552
|
artikel
|
| 14 |
Evaluation of SARS-CoV-2 IgG antibody reactivity in patients with systemic lupus erythematosus: analysis of a multi-racial and multi-ethnic cohort
|
Saxena, Amit
|
|
|
3 |
8 |
p. e585-e594
|
artikel
|
| 15 |
Inflammatory biomarkers in COVID-19-associated multisystem inflammatory syndrome in children, Kawasaki disease, and macrophage activation syndrome: a cohort study
|
Rodriguez-Smith, Jackeline J
|
|
|
3 |
8 |
p. e574-e584
|
artikel
|
| 16 |
NICE guidance for moderate RA—a step in the right direction
|
The Lancet Rheumatology,
|
|
|
3 |
8 |
p. e533
|
artikel
|
| 17 |
Patient and public involvement in rheumatology research: embracing the wave of change
|
Yeoh, Su-Ann
|
|
|
3 |
8 |
p. e540-e542
|
artikel
|
| 18 |
Research in Brief
|
Thorley, Jennifer
|
|
|
3 |
8 |
p. e550
|
artikel
|
| 19 |
Systemic lupus erythematosus does not prevent antibody responses to SARS-CoV-2
|
Aringer, Martin
|
|
|
3 |
8 |
p. e538-e540
|
artikel
|
Tijdschrift beschrijving